FDA approves scPharmaceuticals’ Furoscix sNDA for oedema in CKD

The US FDA has approved scPharmaceuticals’ sNDA for Furoscix, expanding its indication to include oedema treatment…

FDA approves scPharmaceuticals’ Furoscix sNDA for oedema in CKD

The US FDA has approved scPharmaceuticals’ sNDA for Furoscix, expanding its indication to include oedema treatment…

Pfizer appoints former J&J executive to lead obesity drug development – Reuters

Pfizer appoints former J&J executive to lead obesity drug development  Reuters

Does ‘Oatzempic’ Help You Lose Weight? – Verywell Health

Does ‘Oatzempic’ Help You Lose Weight?  Verywell Health

Industry Voices—The GLP-1 status quo is no longer acceptable, but it is changeable. – Fierce healthcare

Industry Voices—The GLP-1 status quo is no longer acceptable, but it is changeable.  Fierce healthcare

The rise of the Ozempic menu and how weight-loss drugs are changing dining out – The Independent

The rise of the Ozempic menu and how weight-loss drugs are changing dining out  The Independent

Weight loss drugs like Ozempic a boon for Streeterville plastic surgery clinic, boosting demand for facelifts – Chicago Sun-Times

Weight loss drugs like Ozempic a boon for Streeterville plastic surgery clinic, boosting demand for facelifts  Chicago…

Is your weight loss drug affecting your relationship? – The Indian Express

Is your weight loss drug affecting your relationship?  The Indian Express

The trillion-dollar opportunity in women’s health

Closing the gap in health interventions between men and women could add $1tn to the global…

FDA ODD given to Plus Therapeutics’ injectable radiotherapy

The FDA has granted orphan drug designation to Plus Therapeutics’ injectable radiotherapy, Rhenium (186Re) Obisbemeda.